Safety Shot SG&A Expenses 2020-2024 | SHOT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Safety Shot sg&a expenses from 2020 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Safety Shot sg&a expenses from 2020 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$196.8B
Stryker (SYK)	$146.2B
Boston Scientific (BSX)	$145.4B
EssilorLuxottica (ESLOY)	$115.4B
Medtronic (MDT)	$112.9B
Lonza Group Ag (LZAGY)	$43.8B
Haleon (HLN)	$41.8B
GE HealthCare Technologies (GEHC)	$38.7B
ResMed (RMD)	$35.2B
Terumo (TRUMY)	$28B
Koninklijke Philips (PHG)	$24.3B
Zimmer Biomet Holdings (ZBH)	$21.8B
Insulet (PODD)	$19.3B
Baxter (BAX)	$15.8B
Smith & Nephew SNATS (SNN)	$11.1B
Bio-Rad Laboratories (BIO)	$9.6B
BellRing Brands (BRBR)	$9.3B
Demant (WILYY)	$8.7B
Lantheus Holdings (LNTH)	$6.4B
ICU Medical (ICUI)	$4B
Prestige Consumer Healthcare (PBH)	$3.9B
Haemonetics (HAE)	$3.7B
Envista Holdings (NVST)	$3.4B
Perrigo (PRGO)	$3.3B
Shandong Weigao Medical Polymer (SHWGF)	$3B
QuidelOrtho (QDEL)	$2.8B
GN Store Nord (GNNDY)	$2.6B
Neogen (NEOG)	$2.5B
LeMaitre Vascular (LMAT)	$2.2B
AtriCure (ATRC)	$1.9B